Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 1998, p. 2443-2445, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Ser315Thr Substitution in KatG Is Predominant in Genetically
Heterogeneous Multidrug-Resistant Mycobacterium
tuberculosis Isolates Originating from the St. Petersburg Area
in Russia
Harri J.
Marttila,1,*
Hanna
Soini,1
Erkki
Eerola,2
Elena
Vyshnevskaya,3
Boris I.
Vyshnevskiy,3
Tatjana F.
Otten,3
Alexandr V.
Vasilyef,3 and
Matti K.
Viljanen1
Mycobacterial Reference Laboratory, National
Public Health Institute,1 and
Department
of Medical Microbiology University of
Turku,2 Kiinamyllynkatu 13, 20520 Turku,
Finland, and
Research Institution of Phthisiopulmonology,
St. Petersburg, Russia3
Received 9 April 1998/Returned for modification 6 May 1998/Accepted 29 June 1998
 |
ABSTRACT |
Parts of katG and rpoB from 27 Russian
Mycobacterium tuberculosis isolates were sequenced to
detect mutations causing resistance to isoniazid (INH) and rifampin
(RMP), respectively. All 24 INH-resistant isolates had a mutated
katG, and 22 of them (91.7%) carried a mutation coding for
a Ser315Thr shift. An rpoB mutation was noted for each of
the 21 RMP-resistant isolates, with Ser531Leu being the most prevalent
change encoded. Only two isolates had identical IS6110
fingerprints.
| |
TEXT |
During the present decade,
notification rates of tuberculosis and resistance rates have grown
substantially in Russia. In 1995, the incidence of tuberculosis in the
Russian Federation was 66 per 100,000, which when compared to the
notification rate of 34 per 100,000 in 1991 reflects an annual increase
rate of 14.2% (12, 13). In a recent survey in northwestern
Russia, initial drug resistance to at least one antituberculous drug
rose from 17.0 to 24.0% from 1991 through 1994, and initial multidrug resistance (i.e., resistance to at least isoniazid [INH] and rifampin [RMP]) was shown in 5.1% of the tuberculosis cases. Acquired
resistance already existed in northwestern Russia 10 years ago, but
since then, the resistance pattern has gradually shifted toward
multidrug resistance (18).
The genetic basis of INH resistance in M. tuberculosis has
been attributed to at least two different genes. Deletion and mutations of the katG gene encoding catalase-peroxidase have been
shown to cause resistance to INH (21). katG
converts INH to an active form, which affects mycobacterial proteins
(such as InhA) that are required for the synthesis of mycolic acids.
Mutations of the inhA operon have been associated with
INH-resistant M. tuberculosis isolates (1, 10,
11). Of the two genes, however, katG seems to be more
frequently altered (11).
Resistance to RMP is based on alterations in the rpoB gene
(15). The most frequently encountered rpoB
mutations in the RMP-resistant isolates are concentrated on a short,
69-bp region of the gene (5, 6, 19), and consequently it has
been possible to develop targeted gene technology applications for
diagnosis of RMP-resistant tuberculosis (2, 3, 19).
This study was based on 27 clinically unrelated M. tuberculosis isolates recovered from the St. Petersburg area in
Russia from November 1993 through March 1995. Löwenstein-Jensen
medium was used for the cultivation of the isolates, and susceptibility testing was done by the proportion method on 7H10 agar (Sensi-Disk; BBL, Becton Dickinson Microbiology Systems, Cockeysville, Md.). Isolates were considered resistant when bacterial growth occurred at a
concentration of 1.0 µg of INH per ml and 5 µg of RMP per ml.
Twenty-one isolates were resistant to INH and RMP, another three showed
resistance to INH only, and the remaining three were susceptible to
both drugs. Resistance to streptomycin, ethionamide, and kanamycin was
also determined (Fig. 1). All the
isolates were subjected to the IS6110 restriction fragment
length polymorphism (RFLP) analysis according to the standard protocol
(17).
View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
IS6110 RFLP patterns, drug resistance data,
and katG- and rpoB-encoded mutations in 27 M. tuberculosis isolates from the St. Petersburg area. Drug
resistance abbreviations: H, INH; R, RMP; Km, kanamycin; Eta,
ethionamide.
|
|
DNA extracted for the RFLP study was used as a template for PCR. For
katG studies, the segment of DNA covering the area coding for amino acids Ser315 and Arg463 was amplified with primers described elsewhere (9). The complete katG was sequenced
from those isolates, which did not have any mutation in the initially
sequenced region of the gene. A 357-bp region of rpoB was
amplified with an upstream primer, RP1
(5'-GGAGCGGATGACCACCCA), and a downstream primer, RB2 (5'-GCGGTACGGCGTTTCGATGAA). The primers were also
synthesized as biotinylated versions, in which a biotin amidite group
(Biodite; Pharmacia Biotech, Espoo, Finland) was added to the
oligonucleotide at the 5' end. The amplification was carried out with a
thermal cycler (GeneAmp PCR System 2400; Perkin-Elmer, Foster City,
Calif.). A total of 40 cycles of denaturation at 94°C for 45 s,
annealing at 60°C for 45 s, and synthesis at 72°C for 45 s were carried out, with a final extension of PCR products at 72°C
for 7 min. The biotinylated PCR products were rendered single-stranded
with streptavidin-coated Dynabeads as described in the manufacturer's instructions (Dynabeads M-280 streptavidin; Dynal AS, Oslo, Norway).
The DNA sequence of both strands was determined with the ABI PRISM dye
terminator with cycle sequencing ready reaction kit with AmpliTaq FS
DNA polymerase and the 373-18 DNA sequencer (Applied Biosystems, Inc.,
Foster City, Calif.). The data were assembled and edited by using SeqEd
v. 1.0.3 software (Applied Biosystems), and the sequences were compared
with the published sequences in the GenBank database.
Twenty-seven M. tuberculosis isolates were investigated by
sequencing and RFLP to evaluate drug resistance mechanisms and to
assess possible genetic similarities between the isolates. Twenty-six
different IS6110 RFLP patterns were obtained. Two isolates produced identical fingerprints, yet their mutational patterns differed
from each other slightly (Fig. 1).
Each INH-resistant isolate had a mutated katG gene (Fig. 1).
The sequencing of this part of katG revealed the mutation
coding for the Ser315Thr substitution in 22 of the 24 (91.7%)
INH-resistant isolates. Every Ser-to-Thr change at position 315 originated from an AGC-to-ACC substitution. Twelve of the 22 isolates
contained substitutions at both positions 315 and 463. The two
remaining INH-resistant isolates that did not contain the Ser315Thr
change had point mutations resulting in either Gln88Arg or Tyr155Ser amino acid shifts. Two INH-susceptible isolates carried the mutation coding for an amino acid substitution at position 463, and one susceptible isolate had a wild-type katG gene.
The sequenced part of rpoB included the 69-bp region, which
is strongly associated with RMP resistance. Each of the 21 RMP-resistant isolates had a mutation in this region, the most
prevalent mutations coding for Ser531Leu (11 isolates) and His526Tyr (3 isolates). One isolate had a point mutation which changed Pro564 to
Leu. This isolate was susceptible to 5 µg of RMP per ml but resistant to a 1-µg/ml concentration.
This study shows that the katG mutation coding for the
Ser315Thr substitution was extremely prevalent among clinically
unrelated M. tuberculosis isolates from the St. Petersburg
area, although the isolates were largely heterogeneous in their
IS6110 RFLP patterns. Of the INH-resistant isolates, 91.7%
carried a katG mutation leading to the Ser315Thr change. In
recent studies, this amino acid substitution has been detected in 44 to
64% of INH-resistant isolates (4, 11). The Ser315Thr change
has been confirmed to cause INH resistance in site-directed mutagenesis
studies, yet 30 to 40% of the proper function of the
catalase-peroxidase remains (14). Recently, Li and coworkers
reported that katG mutations, which result in low-level
enzymatic activities, cause attenuated virulence of M. tuberculosis in mice and guinea pigs (8). However, the
enrichment of the mutation leading to the Ser315Thr substitution among
heterogeneous INH-resistant bacteria supports the advantageousness of
the change for M. tuberculosis.
Since 91.7% of the INH-resistant isolates of the study had the
katG mutation encoding the Ser315Thr substitution that
definitely caused resistance, it is highly unlikely that mutations in
other genes, such as the inhA operon, could significantly
contribute to the resistance. The high prevalence of the single amino
acid shift may help to develop a rapid screening method for the
detection of INH-resistant M. tuberculosis isolates in the
St. Petersburg area, for which the process is under way.
The Arg463Leu shift in KatG was noted in 15 isolates, two of which were
susceptible to 1.0 µg of INH per ml. Rouse et al. reported a MIC of
1.0 µg/ml for an isolate subjected to mutagenesis causing the
Arg463-to-Leu change (14). One of the susceptible isolates
with the shift in our study was resistant to 0.4 µg of INH per ml,
while the other was fully susceptible, which partly agrees with the
finding of Rouse et al. Hence, our results support the earlier ones
that the Arg463Leu substitution in KatG cannot be regarded as a
significant marker for INH resistance in M. tuberculosis (7).
The array of rpoB mutations was similar to those published
in other reports, with Ser531Leu and His526Tyr being the most common substitutions encoded (5, 15, 16, 19). This finding further strengthens the assumption that the mutations of rpoB are
globally responsible for resistance to RMP. Therefore, it is evident
that the new rapid methods for the detection of mutations in
rpoB would be valuable adjuncts in the repertoire of
laboratory methods in the survey area.
Although clonal spread was not markedly noted among these isolates in
the St. Petersburg area, it is hazardous to draw any general
implications concerning the transmission of drug-resistant tuberculosis. A thorough evaluation of the clonality of M. tuberculosis isolates in the study area would demand a greater
number of isolates and the use of an additional typing method, since
IS6110 RFLP patterns change at a relatively rapid rate (20).
To conclude, in our isolates from the St. Petersburg area, a
significant predominance of the Ser315Thr mutation encoded by the
katG sequence among heterogeneous INH-resistant M. tuberculosis isolates was noted. The results further imply that it
would be useful to develop a rapid assay for detecting the mutations
that cause the shift at position 315 and that lead to INH resistance.
| |
ACKNOWLEDGMENTS |
This study was supported by the Finnish Anti-Tuberculosis
Association Foundation and the Finnish National Research and
Development Centre for Welfare and Health/HEDEC infectious diseases
project in St. Petersburg, Russia.
| |
FOOTNOTES |
*
Corresponding author. Mailing address: National Public
Health Institute, Department in Turku, Kiinamyllynkatu 13, 20520 Turku, Finland. Phone: 358-2-2519255. Fax: 358-2-2519254. E-mail:
harmar{at}utu.fi.
| |
REFERENCES |
| 1.
|
Banerjee, A.,
E. Dubnau,
A. Quemard,
V. Balasubramanian,
K. S. Um,
T. Wilson,
D. Collins,
G. de Lisle, and W. R. Jacobs.
1994.
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Science
263:227-230[Abstract/Free Full Text].
|
| 2.
|
De Beenhouwer, H.,
Z. Lhiang,
G. Jannes,
W. Mijs,
L. Machtelinckx,
R. Rossau,
H. Traore, and F. Portaels.
1995.
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay.
Tubercle Lung. Dis.
76:425-430[Medline].
|
| 3.
|
Felmlee, T. A.,
Q. Liu,
C. Whelen,
D. Williams,
S. S. Sommer, and D. H. Persing.
1995.
Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting.
J. Clin. Microbiol.
33:1617-1623[Abstract].
|
| 4.
|
Haas, W. H.,
K. Schilke,
J. Brand,
B. Amthor,
K. Weyer,
P. B. Fourie,
G. Bretzel,
V. Sticht-Groh, and H. J. Bremer.
1997.
Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa.
Antimicrob. Agents Chemother.
41:1601-1603[Abstract].
|
| 5.
|
Kapur, V.,
L.-L. Li,
S. Iordanescu,
M. R. Hamrick,
A. Wanger,
B. N. Kreiswirth, and J. M. Musser.
1994.
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase  subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.
J. Clin. Microbiol.
32:1095-1098[Abstract/Free Full Text].
|
| 6.
|
Kim, B.-J.,
S.-Y. Kim,
B. H. Park,
M.-A. Lyu,
I.-K. Park,
G.-H. Bai,
S.-J. Kim,
C.-Y. Cha, and Y.-H. Kook.
1997.
Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing.
J. Clin. Microbiol.
35:492-494[Abstract].
|
| 7.
|
Lee, A. S.-G.,
L. L.-H. Tang,
I. H.-K. Lim,
M.-L. Ling,
L. Tay, and S.-Y. Wong.
1997.
Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore.
J. Infect. Dis.
176:1125-1126[Medline]. (Letter.)
|
| 8.
|
Li, Z.,
C. Kelley,
F. Collins,
D. Rouse, and S. Morris.
1998.
Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs.
J. Infect. Dis.
177:1003-1035[Medline].
|
| 9.
|
Marttila, H. J.,
H. Soini,
P. Huovinen, and M. K. Viljanen.
1996.
katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients.
Antimicrob. Agents Chemother.
40:2187-2189[Abstract].
|
| 10.
|
Mdluli, K.,
D. R. Sherman,
M. J. Hickey,
B. N. Kreiswirth,
S. Morris,
K. Stover, and C. E. Barry, III.
1996.
Biochemical and genetical data suggest that InhA is not the primary target for activated isoniazid in Mycobacterium tuberculosis.
J. Infect. Dis.
174:1085-1090[Medline].
|
| 11.
|
Musser, J. M.,
V. Kapur,
D. L. Williams,
B. N. Kreiswirth,
D. van Soolingen, and J. D. A. van Embden.
1996.
Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
J. Infect. Dis.
173:196-202[Medline].
|
| 12.
|
Perrocheau, A.,
V. Schwoebel, and J. Veen.
1998.
Surveillance of tuberculosis in the WHO European Region in 1995: results of the feasibility study.
Eurosurveillance
3:2-5.
|
| 13.
|
Raviglione, M. C.,
H. L. Riedel,
K. Styblo,
A. G. Khomenko,
K. Esteves, and A. Kochi.
1994.
Tuberculosis trends in eastern Europe and the former USSR.
Tubercle Lung. Dis.
75:400-416[Medline].
|
| 14.
|
Rouse, D. A.,
J. A. DeVito,
Z. Li,
H. Byer, and S. L. Morris.
1996.
Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance.
Mol. Microbiol.
22:583-592[Medline].
|
| 15.
|
Telenti, A.,
P. Imboden,
F. Marchesi,
D. Lowrie,
S. Cole,
M. J. Colston,
L. Matter,
K. Schopfer, and T. Bodmer.
1993.
Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis.
Lancet
341:647-650[Medline].
|
| 16.
|
Telenti, A.,
N. Honoré,
C. Bernasconi,
J. March,
A. Ortega,
B. Heym,
H. E. Takiff, and S. T. Cole.
1997.
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.
J. Clin. Microbiol.
35:719-723[Abstract].
|
| 17.
|
van Embden, J. D. A.,
M. D. Cave,
J. T. Crawford,
J. W. Dale,
K. D. Eisenach,
B. Gicquel,
P. W. M. Hermans,
C. Martin,
R. McAdam,
T. M. Shinnick, and P. M. Small.
1993.
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.
J. Clin. Microbiol.
31:1987-1995[Abstract/Free Full Text].
|
| 18.
| Viljanen, M. K., B. I. Vyshnevskiy, T. F. Otten, E. Vyshnevskaya, M. Marjamäki, H. Soini, P. J. Laippala, and A. V. Vasilyef. Survey of drug-resistant
tuberculosis in northwestern Russia from 1984 through 1994. Eur.
J. Clin. Microbiol. Infect. Dis., in press.
|
| 19.
|
Williams, D. L.,
C. Waguespack,
K. Eisenach,
J. T. Crawford,
F. Portaels,
M. Salfinger,
C. M. Nolan,
C. Abe,
V. Sticht-Groh, and T. P. Gillis.
1994.
Characterization of rifampin resistance in pathogenic mycobacteria.
Antimicrob. Agents Chemother.
38:2380-2386[Abstract/Free Full Text].
|
| 20.
|
Yeh, R. W.,
A. P. de Leon,
C. B. Agasino,
J. A. Hahn,
C. L. Daley,
P. C. Hopewell, and P. M. Small.
1998.
Stability of Mycobacterium tuberculosis DNA genotypes.
J. Infect. Dis.
177:1107-1111[Medline].
|
| 21.
|
Zhang, Y.,
B. Heym,
B. Allen,
D. Young, and S. Cole.
1992.
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
Nature
358:591-593[Medline].
|
Antimicrobial Agents and Chemotherapy, September 1998, p. 2443-2445, Vol. 42, No. 9
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Metcalfe, C., Macdonald, I. K., Murphy, E. J., Brown, K. A., Raven, E. L., Moody, P. C. E.
(2008). The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases. J. Biol. Chem.
283: 6193-6200
[Abstract]
[Full Text]
-
Gegia, M., Mdivani, N., Mendes, R. E., Li, H., Akhalaia, M., Han, J., Khechinashvili, G., Tang, Y.-W.
(2008). Prevalence of and Molecular Basis for Tuberculosis Drug Resistance in the Republic of Georgia: Validation of a QIAplex System for Detection of Drug Resistance-Related Mutations. Antimicrob. Agents Chemother.
52: 725-729
[Abstract]
[Full Text]
-
Hazbon, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de Leon, A., Alland, D.
(2006). Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis.. Antimicrob. Agents Chemother.
50: 2640-2649
[Abstract]
[Full Text]
-
Cavusoglu, C., Turhan, A., Akinci, P., Soyler, I.
(2006). Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates.. J. Clin. Microbiol.
44: 2338-2342
[Abstract]
[Full Text]
-
Miotto, P., Piana, F., Penati, V., Canducci, F., Migliori, G. B., Cirillo, D. M.
(2006). Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in Italy.. J. Clin. Microbiol.
44: 2485-2491
[Abstract]
[Full Text]
-
Aragon, L. M., Navarro, F., Heiser, V., Garrigo, M., Espanol, M., Coll, P.
(2006). Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J Antimicrob Chemother
57: 825-831
[Abstract]
[Full Text]
-
Makinen, J., Marttila, H. J., Marjamaki, M., Viljanen, M. K., Soini, H.
(2006). Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosis. J. Clin. Microbiol.
44: 350-352
[Abstract]
[Full Text]
-
Zhang, M., Yue, J., Yang, Y.-p., Zhang, H.-m., Lei, J.-q., Jin, R.-l., Zhang, X.-l., Wang, H.-h.
(2005). Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from China. J. Clin. Microbiol.
43: 5477-5482
[Abstract]
[Full Text]
-
Gazouli, M., Ikonomopoulos, J., Koundourakis, A., Bartos, M., Pavlik, I., Overduin, P., Kremer, K., Gorgoulis, V., Kittas, C.
(2005). Characterization of Mycobacterium tuberculosis Complex Isolates from Greek Patients with Sarcoidosis by Spoligotyping. J. Clin. Microbiol.
43: 4858-4861
[Abstract]
[Full Text]
-
Hillemann, D., Weizenegger, M., Kubica, T., Richter, E., Niemann, S.
(2005). Use of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates. J. Clin. Microbiol.
43: 3699-3703
[Abstract]
[Full Text]
-
Parsons, L. M., Salfinger, M., Clobridge, A., Dormandy, J., Mirabello, L., Polletta, V. L., Sanic, A., Sinyavskiy, O., Larsen, S. C., Driscoll, J., Zickas, G., Taber, H. W.
(2005). Phenotypic and Molecular Characterization of Mycobacterium tuberculosis Isolates Resistant to both Isoniazid and Ethambutol. Antimicrob. Agents Chemother.
49: 2218-2225
[Abstract]
[Full Text]
-
Espasa, M., Gonzalez-Martin, J., Alcaide, F., Aragon, L. M., Lonca, J., Manterola, J. M., Salvado, M., Tudo, G., Orus, P., Coll, P.
(2005). Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemother
55: 860-865
[Abstract]
[Full Text]
-
Baker, L. V., Brown, T. J., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., Drobniewski, F. A.
(2005). Molecular Analysis of Isoniazid-Resistant Mycobacterium tuberculosis Isolates from England and Wales Reveals the Phylogenetic Significance of the ahpC -46A Polymorphism. Antimicrob. Agents Chemother.
49: 1455-1464
[Abstract]
[Full Text]
-
Dubiley, S., Mayorova, A., Ignatova, A., Kirillov, E., Stepanshina, V., Kolesnikov, A., Shemyakin, I.
(2005). New PCR-Based Assay for Detection of Common Mutations Associated with Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis. Clin. Chem.
51: 447-450
[Full Text]
-
Herrera-Leon, L., Molina, T., Saiz, P., Saez-Nieto, J. A., Jimenez, M. S.
(2005). New Multiplex PCR for Rapid Detection of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates. Antimicrob. Agents Chemother.
49: 144-147
[Abstract]
[Full Text]
-
Marin, M., de Viedma, D. G., Ruiz-Serrano, M. J., Bouza, E.
(2004). Rapid Direct Detection of Multiple Rifampin and Isoniazid Resistance Mutations in Mycobacterium tuberculosis in Respiratory Samples by Real-Time PCR. Antimicrob. Agents Chemother.
48: 4293-4300
[Abstract]
[Full Text]
-
Bertrand, T., Eady, N. A. J., Jones, J. N., Jesmin, , Nagy, J. M., Jamart-Gregoire, B., Raven, E. L., Brown, K. A.
(2004). Crystal Structure of Mycobacterium tuberculosis Catalase-Peroxidase. J. Biol. Chem.
279: 38991-38999
[Abstract]
[Full Text]
-
Cardoso, R. F., Cooksey, R. C., Morlock, G. P., Barco, P., Cecon, L., Forestiero, F., Leite, C. Q. F., Sato, D. N., Shikama, M. d. L., Mamizuka, E. M., Hirata, R. D. C., Hirata, M. H.
(2004). Screening and Characterization of Mutations in Isoniazid-Resistant Mycobacterium tuberculosis Isolates Obtained in Brazil. Antimicrob. Agents Chemother.
48: 3373-3381
[Abstract]
[Full Text]
-
Ramaswamy, S. V., Dou, S.-J., Rendon, A., Yang, Z., Cave, M. D., Graviss, E. A.
(2004). Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol
53: 107-113
[Abstract]
[Full Text]
-
van Doorn, H. R., Claas, E. C. J., Templeton, K. E., van der Zanden, A. G. M., te Koppele Vije, A., de Jong, M. D., Dankert, J., Kuijper, E. J.
(2003). Detection of a Point Mutation Associated with High-Level Isoniazid Resistance in Mycobacterium tuberculosis by Using Real-Time PCR Technology with 3'-Minor Groove Binder-DNA Probes. J. Clin. Microbiol.
41: 4630-4635
[Abstract]
[Full Text]
-
Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. M., Telles, M. A., Kritski, A., Morlock, G. P., Cooksey, R. C., Zaha, A., Rossetti, M. L. R.
(2003). Mutations in katG, inhA, and ahpC Genes of Brazilian Isoniazid-Resistant Isolates of Mycobacterium tuberculosis. J. Clin. Microbiol.
41: 4471-4474
[Abstract]
[Full Text]
-
Mokrousov, I., Otten, T., Vyshnevskiy, B., Narvskaya, O.
(2003). Allele-Specific rpoB PCR Assays for Detection of Rifampin-Resistant Mycobacterium tuberculosis in Sputum Smears. Antimicrob. Agents Chemother.
47: 2231-2235
[Abstract]
[Full Text]
-
Yu, S., Girotto, S., Lee, C., Magliozzo, R. S.
(2003). Reduced Affinity for Isoniazid in the S315T Mutant of Mycobacterium tuberculosis KatG Is a Key Factor in Antibiotic Resistance. J. Biol. Chem.
278: 14769-14775
[Abstract]
[Full Text]
-
Werngren, J., Hoffner, S. E.
(2003). Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate. J. Clin. Microbiol.
41: 1520-1524
[Abstract]
[Full Text]
-
Puustinen, K., Marjamaki, M., Rastogi, N., Sola, C., Filliol, I., Ruutu, P., Holmstrom, P., Viljanen, M. K., Soini, H.
(2003). Characterization of Finnish Mycobacterium tuberculosis Isolates by Spoligotyping. J. Clin. Microbiol.
41: 1525-1528
[Abstract]
[Full Text]
-
Van Der Zanden, A. G. M., Te Koppele-Vije, E. M., Vijaya Bhanu, N., Van Soolingen, D., Schouls, L. M.
(2003). Use of DNA Extracts from Ziehl-Neelsen-Stained Slides for Molecular Detection of Rifampin Resistance and Spoligotyping of Mycobacterium tuberculosis. J. Clin. Microbiol.
41: 1101-1108
[Abstract]
[Full Text]
-
Chouchane, S., Girotto, S., Kapetanaki, S., Schelvis, J. P. M., Yu, S., Magliozzo, R. S.
(2003). Analysis of Heme Structural Heterogeneity in Mycobacterium tuberculosis Catalase-Peroxidase (KatG). J. Biol. Chem.
278: 8154-8162
[Abstract]
[Full Text]
-
Tracevska, T., Jansone, I., Broka, L., Marga, O., Baumanis, V.
(2002). Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia. J. Clin. Microbiol.
40: 3789-3792
[Abstract]
[Full Text]
-
Mokrousov, I., Otten, T., Vyshnevskiy, B., Narvskaya, O.
(2002). Detection of embB306 Mutations in Ethambutol-Susceptible Clinical Isolates of Mycobacterium tuberculosis from Northwestern Russia: Implications for Genotypic Resistance Testing. J. Clin. Microbiol.
40: 3810-3813
[Abstract]
[Full Text]
-
Pym, A. S., Saint-Joanis, B., Cole, S. T.
(2002). Effect of katG Mutations on the Virulence of Mycobacterium tuberculosis and the Implication for Transmission in Humans. Infect. Immun.
70: 4955-4960
[Abstract]
[Full Text]
-
Toungoussova, O. S., Sandven, P., Mariandyshev, A. O., Nizovtseva, N. I., Bjune, G., Caugant, D. A.
(2002). Spread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia. J. Clin. Microbiol.
40: 1930-1937
[Abstract]
[Full Text]
-
Mokrousov, I., Narvskaya, O., Otten, T., Limeschenko, E., Steklova, L., Vyshnevskiy, B.
(2002). High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother.
46: 1417-1424
[Abstract]
[Full Text]
-
Garcia de Viedma, D., del Sol Diaz Infantes, M., Lasala, F., Chaves, F., Alcala, L., Bouza, E.
(2002). New Real-Time PCR Able To Detect in a Single Tube Multiple Rifampin Resistance Mutations and High-Level Isoniazid Resistance Mutations in Mycobacterium tuberculosis. J. Clin. Microbiol.
40: 988-995
[Abstract]
[Full Text]
-
Sechi, L. A., Zanetti, S., Sanguinetti, M., Molicotti, P., Romano, L., Leori, G., Delogu, G., Boccia, S., La Sorda, M., Fadda, G.
(2001). Molecular Basis of Rifampin and Isoniazid Resistance in Mycobacterium bovis Strains Isolated in Sardinia, Italy. Antimicrob. Agents Chemother.
45: 1645-1648
[Abstract]
[Full Text]
-
Abbadi, S., Rashed, H. G., Morlock, G. P., Woodley, C. L., El Shanawy, O., Cooksey, R. C.
(2001). Characterization of IS6110 Restriction Fragment Length Polymorphism Patterns and Mechanisms of Antimicrobial Resistance for Multidrug-Resistant Isolates of Mycobacterium tuberculosis from a Major Reference Hospital in Assiut, Egypt. J. Clin. Microbiol.
39: 2330-2334
[Abstract]
[Full Text]
-
Van Rie, A., Warren, R., Mshanga, I., Jordaan, A. M, van der Spuy, G. D., Richardson, M., Simpson, J., Gie, R. P., Enarson, D. A., Beyers, N., van Helden, P. D., Victor, T. C.
(2001). Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community. J. Clin. Microbiol.
39: 636-641
[Abstract]
[Full Text]
-
Morlock, G. P., Plikaytis, B. B., Crawford, J. T.
(2000). Characterization of Spontaneous, In Vitro-Selected, Rifampin-Resistant Mutants of Mycobacterium tuberculosis Strain H37Rv. Antimicrob. Agents Chemother.
44: 3298-3301
[Abstract]
[Full Text]
-
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R. Jr., Kramer, F. R., Alland, D.
(2000). Genotypic Analysis of Mycobacterium tuberculosis in Two Distinct Populations Using Molecular Beacons: Implications for Rapid Susceptibility Testing. Antimicrob. Agents Chemother.
44: 103-110
[Abstract]
[Full Text]
-
Marttila, H. J., Marjamäki, M., Vyshnevskaya, E., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., Viljanen, M. K.
(1999). pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates from Northwestern Russia. Antimicrob. Agents Chemother.
43: 1764-1766
[Abstract]
[Full Text]
Top
Abstract
Text
